Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 07.11.2024
Evoke Pharma Мультипликаторы 2011-2024 | EVOK
Мультипликаторы по годам Evoke Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.3 | -1.2 | -2.4 | -5.1 | -4.6 | -6.2 | -3.3 | -2.5 | -1.7 | -2.9 | -8.6 | - | - |
P/S |
0.4 | 3.9 | 12.7 | 2930.4 | - | - | - | - | - | - | - | - | - |
EPS |
-2.3 | -2.6 | -3.2 | -0.5 | -0.3 | -0.5 | -0.8 | -1.1 | -1.9 | -2.2 | -1.2 | -1.8 | -2.2 |
EV (Enterprise Value) |
7.15 млн | 7.73 млн | 18.4 млн | 72 млн | 28.9 млн | 43.1 млн | 38.8 млн | 23.1 млн | 17.9 млн | 31 млн | 3.88 млн | 19.7 млн | 18.6 млн |
EBITDA per Share |
-2.22 | -2.48 | -3.04 | -0.499 | -0.321 | -0.509 | -0.686 | -1.19 | -1.78 | -2.18 | -1.1 | - | - |
EV/EBITDA |
-27.4 | -4.9 | -3.8 | -4.9 | -3.2 | -1.6 | -1.4 | -2.2 | -1.2 | - | - | ||
PEG |
-0.0 | -0.01 | -0.03 | 0.06 | -0.15 | -0.14 | -0.12 | -0.06 | -0.11 | 0.04 | 0.08 | - | - |
P/B |
-0.9 | 2.4 | 5.8 | -21.0 | 7.4 | 11.6 | 18.8 | 7.0 | 5.9 | 4.2 | 1.1 | - | - |
P/CF |
-0.4 | -1.5 | -1.7 | -10.2 | -5.6 | -6.7 | -4.7 | -3.1 | -2.0 | -3.4 | -8.0 | - | - |
ROE % |
302.08 | -201.34 | -240.16 | 409.21 | -162.67 | -187.96 | -564.68 | -283.78 | -349.83 | -144.17 | -13.39 | - | - |
ROA % |
-110.24 | -69.39 | -80.75 | -139.44 | -111.41 | -133.68 | -153.99 | -115.65 | -127.16 | -86.58 | -11.35 | - | - |
ROCE % |
-184.26 | -76.36 | -88.92 | -687.29 | -163.32 | -199.11 | -191.42 | -133.77 | -153.52 | -97.91 | -11.46 | - | - |
Current Ratio |
0.7 | 1.5 | 1.5 | 1.2 | 3.1 | 3.5 | 3.8 | 6.6 | 5.2 | 8.1 | 10.7 | - | - |
DSO |
45.7 | 66.9 | 35.9 | 369.6 | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | 995.4 | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | 5360.9 | - | - | - | - | - | - | - | - | - |
Операционный цикл |
45.7 | 66.9 | 35.9 | 1365.0 | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
45.7 | 66.9 | 35.9 | -3995.9 | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Evoke Pharma
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.94 | -0.93 | -0.17 | - | -6.08 | -6.71 | -0.67 | - | -0.6 | -0.71 | -0.8 | - | -0.73 | -0.85 | -0.08 | - | -0.08 | -0.28 | -0.07 | -0.06 | -0.07 | -0.09 | -0.11 | -0.1 | -0.09 | -0.14 | -0.13 | -0.02 | -0.34 | -0.11 | -0.37 | -0.12 | -0.29 | -0.41 | -0.45 | -0.37 | -0.42 | -0.52 | -0.58 | -0.48 | -0.63 | -0.59 | -0.49 | -0.27 | -0.41 | -0.21 | -0.44 | -0.6 | -0.43 | -0.32 | -0.45 | - | - | - | - |
EBITDA per Share |
-0.92 | -0.9 | -0.17 | - | -5.76 | -6.41 | -0.64 | - | -0.57 | -0.67 | -0.75 | - | -0.68 | -0.8 | -0.08 | - | -0.08 | -0.28 | -0.07 | - | -0.07 | -0.09 | -0.11 | - | -0.09 | -0.14 | -0.16 | - | -0.24 | -0.19 | -0.15 | - | -0.2 | -0.4 | -0.44 | - | -0.41 | -0.51 | -0.56 | - | -0.63 | -0.58 | -0.49 | - | -0.41 | -0.18 | -0.29 | - | -0.42 | - | - | - | - | - | - |
ROE % |
71.22 | 295.00 | -4.41 | -258.59 | -294.99 | -525.25 | -209.35 | -179.85 | -221.11 | -225.97 | -233.31 | -113.01 | -46.78 | 60.71 | 315.85 | 338.67 | 306.29 | 202.89 | -62.11 | -162.67 | -174.03 | -174.61 | -183.57 | -187.96 | -158.47 | -362.81 | -380.67 | -564.68 | -590.76 | -428.54 | -431.89 | -283.78 | -319.19 | -318.26 | -333.38 | -349.83 | -305.87 | -268.56 | -213.62 | -144.17 | -120.03 | -80.69 | -43.22 | -13.39 | -2.34 | 2.43 | 3.56 | 5.89 | 2.47 | - | - | - | - | - | - |
ROA % |
-53.97 | -66.27 | -76.63 | -64.71 | -79.73 | -73.18 | -67.88 | -54.60 | -71.51 | -73.40 | -70.94 | -43.45 | -66.02 | -71.69 | -132.49 | -115.40 | -137.57 | -140.46 | -99.66 | -111.41 | -120.35 | -121.74 | -129.38 | -133.68 | -106.46 | -145.63 | -125.41 | -153.99 | -166.54 | -133.07 | -144.56 | -115.65 | -126.74 | -122.89 | -124.93 | -127.16 | -118.80 | -115.22 | -104.50 | -86.88 | -74.18 | -51.01 | -28.69 | -11.35 | -584.52 | -1001.71 | -1000.75 | -998.77 | -419.14 | - | - | - | - | - | - |
ROCE % |
-28.57 | -57.14 | -83.00 | -80.21 | -96.79 | -84.81 | -75.13 | -59.52 | -77.50 | -78.89 | -81.86 | -56.99 | -166.53 | -258.10 | -605.84 | -570.92 | -608.29 | -536.10 | -217.69 | -130.81 | -168.64 | -169.10 | -177.91 | -155.17 | -326.10 | -459.19 | -535.32 | -395.78 | -453.05 | -339.41 | -282.50 | -217.02 | -293.72 | -313.14 | -327.96 | -267.46 | -309.04 | -273.93 | -220.60 | -111.39 | -113.69 | -74.39 | -37.35 | -4.82 | -2.39 | 2.33 | 3.29 | 2.43 | 2.43 | - | - | - | - | - | - |
Current Ratio |
1.4 | 1.3 | 1.4 | 0.7 | 0.9 | 1.1 | 1.3 | 1.5 | 1.7 | 2.0 | 1.3 | 1.5 | 1.7 | 1.5 | 1.7 | 0.8 | 0.8 | 0.8 | 0.8 | 3.2 | 3.2 | 3.2 | - | 3.5 | 3.5 | 4.5 | 4.7 | 1.4 | 1.4 | 1.4 | 1.4 | 1.7 | 1.7 | 1.7 | 1.7 | 1.6 | 1.6 | 1.6 | 1.6 | 2.5 | 2.5 | 2.5 | 2.5 | 6.6 | 6.6 | 6.6 | 6.6 | 0.1 | 0.1 | - | - | - | - | - | - |
DSO |
69.2 | 61.8 | 55.9 | - | 65.9 | 69.0 | 73.9 | - | 57.1 | 77.5 | 77.9 | - | 20.6 | 62.9 | 76.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
69.2 | 61.8 | 55.9 | - | 65.9 | 69.0 | 73.9 | - | 57.1 | 77.5 | 77.9 | - | 20.6 | 62.9 | 76.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
69.2 | 61.8 | 55.9 | - | 65.9 | 69.0 | 73.9 | - | 57.1 | 77.5 | 77.9 | - | 20.6 | 62.9 | 76.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD